Paper36911371
Tranilast reduces cardiomyocyte injury induced by ischemia‑reperfusion via Nrf2/HO‑1/NF‑κB signaling.
Wang W and 1 other. Exp Ther Med, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Tranilast reduces cardiomyocyte injury induced by ischemia‑reperfusion via Nrf2/HO‑1/NF‑κB signaling. Papers, record 36911371. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911371
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tranilast reduces cardiomyocyte injury induced by ischemia‑reperfusion via Nrf2/HO‑1/NF‑κB signaling.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30548101 | Tranilast Treatment Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through the Inhibition of Inflammatory Responses Mediated by NF-κB and PPARs. | Clin Transl Sci | 2019 | https://conductscience.org/library/papers/30548101 | PubMed |
| 2 | 34903320 | Potential application of biomimetic exosomes in cardiovascular disease: focused on ischemic heart disease. | BMB Rep | 2022 | https://conductscience.org/library/papers/34903320 | PubMed |
| 3 | 32754591 | Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32754591 | PubMed |
| 4 | 20067475 | The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20067475 | PubMed |
| 5 | 33383049 | Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats. | Life Sci | 2021 | https://conductscience.org/library/papers/33383049 | PubMed |
| 6 | 27165596 | [Tranilast inhibits myocardial fibrosis in mice with viral myocarditis]. | Zhongguo Dang Dai Er Ke Za Zhi | 2016 | https://conductscience.org/library/papers/27165596 | PubMed |
| 7 | 23958925 | Effect of a novel nuclear factor-κB activation inhibitor on renal ischemia-reperfusion injury. | Transplantation | 2013 | https://conductscience.org/library/papers/23958925 | PubMed |
| 8 | 26073877 | A high calorie diet causes memory loss, metabolic syndrome and oxidative stress into hippocampus and temporal cortex of rats. | Synapse | 2015 | https://conductscience.org/library/papers/26073877 | PubMed |
| 9 | 32476536 | Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/32476536 | PubMed |
| 10 | 28067846 | The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China. | Int J Environ Res Public Health | 2017 | https://conductscience.org/library/papers/28067846 | PubMed |
| 11 | 25047843 | Porphyromonas gingivalis-induced reactive oxygen species activate JAK2 and regulate production of inflammatory cytokines through c-Jun. | Infect Immun | 2014 | https://conductscience.org/library/papers/25047843 | PubMed |
| 12 | 30837406 | [Role of Nrf2/HO-1 signal axis in the mechanisms for oxidative stress-relevant diseases]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2019 | https://conductscience.org/library/papers/30837406 | PubMed |
| 13 | 15097224 | Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug. | J Hypertens | 2004 | https://conductscience.org/library/papers/15097224 | PubMed |
| 14 | 33750216 | Effects of Tranilast on Inflammasome and Macrophage Phenotype in a Mouse Model of Myocardial Infarction. | J Interferon Cytokine Res | 2021 | https://conductscience.org/library/papers/33750216 | PubMed |
| 15 | 31249649 | Mangiferin Attenuates Myocardial Ischemia-Reperfusion Injury via MAPK/Nrf-2/HO-1/NF-κB In Vitro and In Vivo. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31249649 | PubMed |
| 16 | 24348025 | Evolution of cardiovascular risk factors and ischemic heart disease in an elderly urban Romanian population over the course of 1 year. | Clin Interv Aging | 2013 | https://conductscience.org/library/papers/24348025 | PubMed |
| 17 | 17701679 | Malondialdehyde content and circadian variations in brain, kidney, liver, and plasma of mice. | Chronobiol Int | 2007 | https://conductscience.org/library/papers/17701679 | PubMed |
| 18 | 20573806 | Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. | Nephrol Dial Transplant | 2011 | https://conductscience.org/library/papers/20573806 | PubMed |
| 19 | 7523821 | Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro. | Life Sci | 1994 | https://conductscience.org/library/papers/7523821 | PubMed |
| 20 | 34174504 | Anti-cancer effects of Tranilast: An update. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34174504 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41511297 | Tranilast Does Not Inhibit TRPV2. | Cells | 2025 | https://conductscience.org/library/papers/41511297 | PubMed |
| 41303485 | Inflammasomes as Potential Therapeutic Targets to Prevent Chronic Active Viral Myocarditis-Translating Basic Science into Clinical Practice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303485 | PubMed |
| 40727576 | The role of Nrf2 signaling pathway in diabetic cardiomyopathy: from pathogenesis to traditional Chinese medicine interventions. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40727576 | PubMed |
| 40427458 | Vitamin C Inhibits Scale Drop Disease Virus Infectivity by Targeting Nrf2 to Reduce Ferroptosis. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427458 | PubMed |
| 39408587 | Potential of NRF2 Inhibitors-Retinoic Acid, K67, and ML-385-In Overcoming Doxorubicin Resistance in Promyelocytic Leukemia Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408587 | PubMed |
| 39169204 | Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39169204 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36911371
GET https://conductscience.org/api/papers/v1/36911371/references?page=2